Biogen Acquires Remedy Pharmaceuticals’ CiraraBusiness, Fast Track Designation, Ischemic Stroke, Large Hemispheric Infarction, M&ARemedy Pharmaceuticals announced that Biogen completed an asset purchase of its Phase 3 candidate, Cirara. Read more May 18, 2017/by Business Wire https://www.pharmalive.com/wp-content/uploads/2020/01/Pharmalive_4c-300x37.png 0 0 Business Wire https://www.pharmalive.com/wp-content/uploads/2020/01/Pharmalive_4c-300x37.png Business Wire2017-05-18 09:00:322017-05-18 13:10:21Biogen Acquires Remedy Pharmaceuticals’ Cirara
